Cancer Survivorship Research

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Cancer survivorship research investigates the long-term physical, psychological, and social well-being of individuals who have undergone cancer treatment. This field examines the late effects of cancer and its therapies, including chronic pain, fatigue, cardiovascular issues, and cognitive changes. Researchers employ diverse methodologies, such as longitudinal studies, patient-reported outcome measures, and qualitative interviews, to understand the lived experiences of survivors. Key areas of focus include developing interventions to improve quality of life, addressing disparities in survivorship care, and exploring the role of lifestyle factors like diet and exercise in recovery.

This research holds particular relevance for Arkansas, a state that faces significant cancer burdens and health disparities. Understanding the unique challenges faced by cancer survivors in Arkansas, including access to follow-up care and supportive services, is crucial for developing targeted public health initiatives. The work directly informs strategies to improve health outcomes and reduce the long-term economic and social costs associated with cancer across the state.

This research area draws upon expertise from health disparities, health literacy, communication, and healthcare policy. Engagement extends across institutions, fostering a collaborative approach to addressing the complex needs of cancer survivors in Arkansas.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Pearman D. Parker UAMS 9 489
Jacquelene Childs UAMS 9 342

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
1 works in 2030
-52.4% CAGR 2018–2030
Leadership concentration
7.2% held by global top 5 institutions
Fragmented HHI 40
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2030 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,727
  2. 2 Harvard University 2,231
  3. 3 Memorial Sloan Kettering Cancer Center 2,213
  4. 4 Dana-Farber Cancer Institute 2,053
  5. 5 University of North Carolina at Chapel Hill 1,964
Browse All 2 Researchers in Directory